Healthcare Services Group (HCSG) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Q2 2024 revenue reached $426.3 million, up 1.8% year-over-year and in line with expectations, with a net loss of $1.8 million and diluted EPS of ($0.02), primarily due to $0.22 per share in client restructuring charges from LaVie Care Centers' bankruptcy.
Cash flow from operations was $16.3 million, with adjusted cash flow used in operations at $2.4 million; over 96% cash collections were achieved, showing improvement over prior periods.
The company reaffirmed its 2024 adjusted cash flow target of $40–$55 million, expecting to recover $12–$15 million in delayed collections related to the Change Healthcare cyberattack in H2.
Industry fundamentals are improving, with workforce availability rising, occupancy at 79.3% (near pre-pandemic levels), and a stable reimbursement environment, including a proposed 4.1% Medicare rate increase for FY2025.
Strategic priorities for H2 2024 include managing cost of services within the 86% target, driving revenue growth, and improving cash collections.
Financial highlights
Q2 2024 revenues were $426.3 million, up from $418.9 million in Q2 2023; net loss was $1.8 million compared to net income of $8.3 million in Q2 2023.
Housekeeping and Laundry segment revenue was $191 million with an 8.9% margin; Dining and Nutrition segment revenue was $235.3 million with a 6.3%–6.4% margin.
Cost of services was $384.7 million (90.2%–90.3% of revenue), including $21.9 million in client restructuring bad debt and $9.8 million in aging-related bad debt.
SG&A expenses were $44.4 million (10.4% of revenue), up from $41.4 million (9.9%) in Q2 2023, with a target range of 8.5%–9.5%.
Adjusted EBITDA was $4.0 million (0.9% of revenue), down from $17.4 million (4.2%) in Q2 2023, with a new calculation method excluding bad debt and self-insurance actuarial adjustments.
Outlook and guidance
Q3 and Q4 2024 revenue estimates raised to $425–$435 million and $430–$440 million, respectively.
2024 adjusted cash flow forecast reaffirmed at $40–$55 million, with expectations to recover delayed collections in H2.
Long-term, the company anticipates mid-single digit top-line growth over the next 3–5 years, with potential for higher growth in some periods.
Management expects continued pressure from inflation and labor costs, with ongoing efforts to pass through cost increases to customers and maintain internal cost controls.
The company believes cash from operations, existing cash, and credit lines will be adequate for foreseeable needs, but notes potential risks from customer payment delays and industry reimbursement changes.
Latest events from Healthcare Services Group
- Revenue up 7.1% to $1.84B, net income $59.1M, $75M buyback, 2026 growth outlook strong.HCSG
Q4 202511 Feb 2026 - Q3 2024 revenue and net income grew, with strong cash flow and reaffirmed guidance.HCSG
Q3 202419 Jan 2026 - Q1 2025 saw record revenue, higher net income, and raised cash flow guidance.HCSG
Q1 202523 Dec 2025 - Q4 revenue grew to $437.8M, but net income and margins fell; 2025 growth expected.HCSG
Q4 202423 Dec 2025 - 2024 saw growth, high retention, and strong governance, with key votes on directors, pay, and audit.HCSG
Proxy Filing1 Dec 2025 - Q2 revenue up 7.6%, $61.2M charge drives $32.4M loss, $50M buyback and higher cash flow planned.HCSG
Q2 202516 Nov 2025 - Q3 revenue up 8.5% to $464.3M, net income $43M, aided by ERC refunds and strong segment growth.HCSG
Q3 202524 Oct 2025